Total Payments
$776.59
2023 Payments
$124.46
Companies
9
Transactions
14
Medicare Patients
3,126
Medicare Billing
$1.1M

Payment Breakdown by Category

Travel$401.02 (51.6%)
Food & Beverage$375.57 (48.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $401.02 1 51.6%
Food and Beverage $375.57 13 48.4%

Top Paying Companies

Company Total Records Latest Year
Olympus Corporation of the Americas $401.02 1 $0 (2017)
GENZYME CORPORATION $124.46 1 $0 (2023)
ABBVIE INC. $98.07 3 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $38.84 2 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $36.21 2 $0 (2021)
PFIZER INC. $28.52 2 $0 (2022)
Olympus America Inc. $20.74 1 $0 (2018)
Organon LLC $15.69 1 $0 (2021)
Daiichi Sankyo Inc. $13.04 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2023 $124.46 1 GENZYME CORPORATION ($124.46)
2022 $128.47 5 ABBVIE INC. ($98.07)
2021 $89.31 5 Takeda Pharmaceuticals U.S.A., Inc. ($36.21)
2020 $12.59 1 PFIZER INC. ($12.59)
2018 $20.74 1 Olympus America Inc. ($20.74)
2017 $401.02 1 Olympus Corporation of the Americas ($401.02)

All Payment Transactions

14 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/14/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $124.46 General
Category: Immunology
07/25/2022 PFIZER INC. XELJANZ (Drug), PAXLOVID Food and Beverage In-kind items and services $15.93 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
05/03/2022 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $68.85 General
Category: ENDOCRINOLOGY
02/25/2022 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $12.00 General
Category: ENDOCRINOLOGY
01/28/2022 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $17.22 General
Category: GASTROENTEROLOGY
01/11/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $14.47 General
Category: Gastroenterology
12/06/2021 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $13.04 General
Category: Iron Deficiency Anemia
12/03/2021 Organon LLC Food and Beverage In-kind items and services $15.69 General
11/08/2021 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $15.52 General
Category: INTERNAL MEDICINE
09/20/2021 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $20.69 General
08/04/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.37 General
Category: Gastroenterology
02/17/2020 PFIZER INC. INFLECTRA (Biological) Food and Beverage In-kind items and services $12.59 General
Category: INFLAMMATION
05/15/2018 Olympus America Inc. Olympus EMR & ESD Devices (Device) Food and Beverage In-kind items and services $20.74 General
Category: EndoTherapy Products
10/06/2017 Olympus Corporation of the Americas EVIS EXERA (Device), Olympus Capital Accessories, Olympus Endoscopic Ultrasound Scopes Travel and Lodging In-kind items and services $401.02 General
Category: GI & Respiratory Products

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 879 943 $873,004 $106,682
2022 16 625 3,975 $607,943 $118,367
2021 25 811 19,226 $1.3M $410,196
2020 21 811 18,536 $1.2M $420,642
Total Patients
3,126
Total Services
42,680
Medicare Billing
$1.1M
Procedure Codes
76

All Medicare Procedures & Services

76 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 163 166 $248,280 $34,283 13.8%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 154 156 $200,964 $15,420 7.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 171 219 $57,213 $14,178 24.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 147 153 $107,014 $10,705 10.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 54 54 $70,584 $9,719 13.8%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 30 32 $40,854 $5,510 13.5%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 31 31 $45,535 $3,947 8.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 25 25 $10,896 $2,610 24.0%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 19 21 $17,971 $2,587 14.4%
43255 Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 14 14 $14,025 $2,148 15.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 20 21 $8,106 $1,948 24.0%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 24 24 $14,958 $1,883 12.6%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 14 14 $10,808 $1,573 14.6%
45381 Injection beneath lining of large bowel using a flexible endoscope Facility 2023 13 13 $25,796 $170.78 0.7%
J3380 Injection, vedolizumab, 1 mg Office 2022 11 3,300 $122,100 $52,096 42.7%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 81 81 $111,231 $16,048 14.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 112 132 $33,044 $9,651 29.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 93 93 $107,319 $8,790 8.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 90 92 $58,968 $6,375 10.8%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 26 26 $35,932 $4,710 13.1%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 22 22 $28,457 $3,921 13.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 29 29 $11,426 $2,736 23.9%
43255 Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 17 18 $16,860 $2,735 16.2%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 22 22 $33,568 $2,608 7.8%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 25 25 $13,945 $2,183 15.7%

About Dr. Iskandar Barakat, M.D

Dr. Iskandar Barakat, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1356624779.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iskandar Barakat, M.D has received a total of $776.59 in payments from pharmaceutical and medical device companies, with $124.46 received in 2023. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Travel and Lodging" ($401.02).

As a Medicare-enrolled provider, Barakat has provided services to 3,126 Medicare beneficiaries, totaling 42,680 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.

Practice Information

Products in Payments

  • EVIS EXERA (Device) $401.02
  • DUPIXENT (Biological) $124.46
  • CREON (Drug) $80.85
  • XIFAXAN (Drug) $24.37
  • Olympus EMR & ESD Devices (Device) $20.74
  • LINZESS (Drug) $17.22
  • XELJANZ (Drug) $15.93
  • ENTYVIO (Biological) $15.52
  • TRULANCE (Drug) $14.47
  • INJECTAFER (Drug) $13.04
  • INFLECTRA (Biological) $12.59

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Staten Island